The Hopewell Foundation for Regenerative Medicine is dedicated to accelerating the development and clinical translation of patient-specific bone and cartilage technologies for nasal reconstruction, including emerging advances in 3D bioprinting and tissue engineering.
Across the world, researchers, startups, and academic institutions are making remarkable progress in this field. However, many promising innovations face significant barriers on the path to patients, including limited funding, regulatory hurdles, manufacturing challenges, and a lack of support for late-stage clinical development.
As a foundation founded by patients, for patients, we are uniquely positioned to help bridge these gaps. Our mission is to support the responsible advancement of regenerative technologies through the final stages of development—whether by funding research, supporting clinical trials, fostering collaboration among stakeholders, or helping navigate the translational pathway.
We also seek to raise awareness of what we believe is a substantial and often overlooked unmet medical need. Every year, thousands of patients require complex nasal reconstruction due to trauma, cancer, congenital conditions, or prior surgical complications. Many face multiple surgeries, donor-site morbidity, and limited reconstructive options. Through advocacy, education, and collaboration, we aim to ensure that innovative regenerative solutions reach the patients who need them most.
We believe the future of reconstruction should not require sacrificing healthy tissue elsewhere in the body. By supporting the development of patient-specific regenerative bone and cartilage, we hope to help create a future where reconstruction is more effective, less invasive, and more accessible for patients worldwide.
